What Researchers Did
Researchers conducted a systematic review and meta-analysis of six randomized controlled trials to evaluate if hyperbaric oxygen therapy helps adults with acute carbon monoxide poisoning, including a subgroup analysis for treatments at or above 2.5 atmospheres absolute (ATA).
What They Found
The analysis of six studies found no significant benefit of hyperbaric oxygen therapy in reducing mortality or improving neurological outcomes for acute carbon monoxide poisoning. A subgroup analysis of treatments at 2.5 ATA or higher also showed no significant advantage over control treatments. The quality of evidence across the included studies was rated as low to very low, with moderate to significant differences between them.
What This Means for Canadian Patients
This review suggests that hyperbaric oxygen therapy may not significantly improve survival or brain function for Canadian patients with acute carbon monoxide poisoning. Patients and doctors should consider this evidence when making treatment decisions, as current research does not strongly support its use for these specific outcomes.
Canadian Relevance
This study covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
A key limitation of this study is that the included research had varying methods and was rated as having low to very low quality evidence.